{
    "organizations": [],
    "uuid": "fa877511a733f9c864b0b2f4433bed5a6ca74cce",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-kitov-announces-consensi-commercia/brief-kitov-announces-consensi-commercialization-agreement-for-china-idUSFWN1SI15Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Kitov Announces Consensi Commercialization Agreement For China",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 11 (Reuters) - Kitov Pharma Ltd:\n* KITOV ANNOUNCES CONSENSIâ„¢ COMMERCIALIZATION AGREEMENT FOR CHINA\n* KITOV PHARMA LTD - KITOV IS ENTITLED TO RECEIVE UP TO OF $3.5 MILLION FOR U.S. FDA APPROVAL OF CONSENSI, WHICH HAS A PDUFA DATE OF MAY 31\n* KITOV PHARMA LTD - RECEIVVAL UP TO OF $3.5 MILLION FOR U.S. FDA APPROVAL OF CONSENSI AND ALSO FOR CHINA REGULATORY MILESTONES\n* KITOV PHARMA - UPON RECEIPT OF MARKETING AUTHORIZATION IN CHINA, CHANGSHAN PHARMA WILL HAVE EXCLUSIVE RIGHT & LICENSE TO IMPORT SELL CONSENSI IN CHINA\n* KITOV PHARMA LTD - CHANGSHAN PHARMA WILL BE RESPONSIBLE FOR FINANCING AND SEEKING REGULATORY APPROVAL FOR CONSENSI IN CHINA\n* KITOV PHARMA LTD - KITOV IS ENTITLED TO RECEIVE UP TO AN OF $6.0 MILLION FOR PREDEFINED COMMERCIAL MILESTONES\n* KITOV PHARMA LTD - KITOV IS ALSO ENTITLED TO RECEIVE UP TO 12% ROYALTIES ON NET SALES Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-11T20:35:00.000+03:00",
    "crawled": "2018-05-12T17:33:23.069+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "kitov",
        "pharma",
        "ltd",
        "kitov",
        "announces",
        "commercialization",
        "agreement",
        "china",
        "kitov",
        "pharma",
        "ltd",
        "kitov",
        "entitled",
        "receive",
        "million",
        "fda",
        "approval",
        "consensi",
        "pdufa",
        "date",
        "may",
        "kitov",
        "pharma",
        "ltd",
        "receivval",
        "million",
        "fda",
        "approval",
        "consensi",
        "also",
        "china",
        "regulatory",
        "milestone",
        "kitov",
        "pharma",
        "upon",
        "receipt",
        "marketing",
        "authorization",
        "china",
        "changshan",
        "pharma",
        "exclusive",
        "right",
        "license",
        "import",
        "sell",
        "consensi",
        "china",
        "kitov",
        "pharma",
        "ltd",
        "changshan",
        "pharma",
        "responsible",
        "financing",
        "seeking",
        "regulatory",
        "approval",
        "consensi",
        "china",
        "kitov",
        "pharma",
        "ltd",
        "kitov",
        "entitled",
        "receive",
        "million",
        "predefined",
        "commercial",
        "milestone",
        "kitov",
        "pharma",
        "ltd",
        "kitov",
        "also",
        "entitled",
        "receive",
        "royalty",
        "net",
        "sale",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}